Literature DB >> 21091897

Model for end-stage liver disease combined with serum prealbumin to predict the prognosis of patients with decompensated liver cirrhosis.

Fei Liu1, Ling Yan Cai, Lan Zhong, Chi Chen, Fei Xu, Zhong Xin Zhao, Xi Mei Chen.   

Abstract

OBJECTIVE: To evaluate the prognostic value of model for end-stage liver disease (MELD) combined with serum prealbumin (PA) in patients with decompensated liver cirrhosis.
METHODS: A total of 252 patients were enrolled in the study and followed 1 year. PA was measured and MELD score was calculated on the first day of admission. Analysis of variance (anova) was used to assess correlation between PA level and MELD score. Multivariable Cox proportional hazards model was used to screen the prognosis related factors. Kaplan-Meier survival curves were drawn.
RESULTS: Of the 252 patients, 28 died within 3 months, 58 within 6 months and 91 within 1 year. Serum PA level in dead patients was significantly lower than that in survival patients (P < 0.005) and decreasing with increasing of MELD score. Cox analysis showed that MELD score > 18 (RR = 2.749) and PA < 70 mg/L (RR = 2.412) were independent prognosis risk factors. The risk ratio of MELD score combined with PA level (1.854, P < 0.01) was higher than that of MELD score alone (1.054, P < 0.05). Kaplan-Meier survival curve analysis showed that MELD score ≤ 18 combined with PA ≥ 70 mg/L could clearly discriminate patients who would survive or die within 6 month and 1 year follow up.
CONCLUSION: MELD score ≤ 18 combined with PA ≥ 70 mg/L could predict the 6-month and 1-year prognosis of patients with decompensated liver cirrhosis, and was superior to that of MELD score alone.
© 2010 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21091897     DOI: 10.1111/j.1751-2980.2010.00465.x

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  8 in total

1.  A simple and effective prognostic staging system based on clinicopathologic features of intrahepatic cholangiocarcinoma.

Authors:  Huabang Zhou; Xiaolan Jiang; Qiaomei Li; Jingyi Hu; Zhengrong Zhong; Hao Wang; Hui Wang; Bing Yang; Heping Hu
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

Review 2.  Model for End-stage Liver Disease.

Authors:  Ashwani K Singal; Patrick S Kamath
Journal:  J Clin Exp Hepatol       Date:  2012-12-01

3.  Liver reserve function assessment by acoustic radiation force impulse imaging.

Authors:  Xiao-Lan Sun; Li-Wei Liang; Hui Cao; Qiong Men; Ke-Zhu Hou; Zhen Chen; Ya-E Zhao
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

4.  Evaluation of plasma leptin, tumor necrosis factor-α, and prealbumin as prognostic biomarkers during clinical recovery from acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Anant Mohan; Sneh Arora; Arvind Uniyal; Rosemary Poulose; Kalpana Luthra; R M Pandey; Randeep Guleria
Journal:  Lung India       Date:  2017 Jan-Feb

5.  Establishment and Validation of a Non-Invasive Diagnostic Nomogram to Identify Spontaneous Bacterial Peritonitis in Patients With Decompensated Cirrhosis.

Authors:  Shoushu Xiang; Juntao Tan; Chao Tan; Qian Xu; Yuanjiu Wen; Tiantian Wang; Chen Yang; Wenlong Zhao
Journal:  Front Med (Lausanne)       Date:  2022-01-31

6.  Preliminary Evidence for a Relationship between Elevated Plasma TNFα and Smaller Subcortical White Matter Volume in HCV Infection Irrespective of HIV or AUD Comorbidity.

Authors:  Natalie M Zahr; Kilian M Pohl; Allison J Kwong; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 6.208

7.  The value of serum prealbumin in the diagnosis and therapeutic response of tuberculosis: a retrospective study.

Authors:  Hu Luo; Bingjing Zhu; Liang Gong; Jingxiang Yang; Yongyuan Jiang; Xiangdong Zhou
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

Review 8.  Nutritional Challenges in Patients with Advanced Liver Cirrhosis.

Authors:  Jessica Stirnimann; Guido Stirnimann
Journal:  J Clin Med       Date:  2019-11-09       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.